Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
96.24
-0.02 (-0.02%)
Dec 19, 2025, 4:00 PM EST - Market closed
Revvity Revenue
Revvity had revenue of $698.95M in the quarter ending September 28, 2025, with 2.18% growth. This brings the company's revenue in the last twelve months to $4.84B, up 1.31% year-over-year. In the year 2024, Revvity had annual revenue of $2.76B with 0.16% growth.
Revenue (ttm)
$4.84B
Revenue Growth
+1.31%
P/S Ratio
4.06
Revenue / Employee
$255,761
Employees
11,000
Market Cap
10.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
| Dec 30, 2018 | 2.78B | 521.01M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.47M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.69M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | -108.90M | -6.56% |
| Dec 28, 2008 | 1.66B | -69.21M | -4.00% |
| Dec 30, 2007 | 1.73B | 251.19M | 17.00% |
| Dec 31, 2006 | 1.48B | 3.85M | 0.26% |
| Jan 1, 2006 | 1.47B | 44.74M | 3.13% |
| Jan 2, 2005 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
RVTY News
- 1 day ago - Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire
- 3 days ago - Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - Business Wire
- 17 days ago - Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy - Business Wire
- 5 weeks ago - Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities - Business Wire
- 7 weeks ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga